NASDAQ
Coeptis Therapeutics, Inc. (COEP) has a fcf yield of -14.26% as of Friday, May 29, 2026. This represents a 16.80% increase compared to its 12-month average of -17.13%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.